FOLD icon

Amicus Therapeutics

280 hedge funds and large institutions have $2.53B invested in Amicus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 113 increasing their positions, 87 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

2% less funds holding

Funds holding: 286280 (-6)

12% less capital invested

Capital invested by funds: $2.87B → $2.53B (-$349M)

36% less call options, than puts

Call options by funds: $3.21M | Put options by funds: $5.04M

Holders
280
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.21M
Puts
$5.04M
Net Calls
Net Calls Change

Top Buyers

1 +$24.4M
2 +$23.7M
3 +$20.2M
4
Bank of America
Bank of America
North Carolina
+$12.7M
5
Two Sigma Investments
Two Sigma Investments
New York
+$8.94M

Top Sellers

1 -$28.6M
2 -$22.7M
3 -$21.8M
4
JP Morgan Chase
JP Morgan Chase
New York
-$18.9M
5
State Street
State Street
Massachusetts
-$6.87M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$230K
177
$228K
178
$220K
179
$205K
180
$204K
181
$195K
182
$195K
183
$194K
184
$191K
185
$189K
186
$181K
187
$181K
188
$178K
189
$177K
190
$176K
191
$175K
192
$175K
193
$175K
194
$167K
195
$162K
196
$158K
197
$152K
198
$148K
199
$139K
200
$131K